These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 11371498)

  • 1. Advanced glycation: an important pathological event in diabetic and age related ocular disease.
    Stitt AW
    Br J Ophthalmol; 2001 Jun; 85(6):746-53. PubMed ID: 11371498
    [No Abstract]   [Full Text] [Related]  

  • 2. Aging and Vision.
    Alavi MV
    Adv Exp Med Biol; 2016; 854():393-9. PubMed ID: 26427437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seeing into the future. Vision and aging.
    Kalina RE
    West J Med; 1997 Oct; 167(4):253-7. PubMed ID: 9348756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular disease and driving.
    Wood JM; Black AA
    Clin Exp Optom; 2016 Sep; 99(5):395-401. PubMed ID: 27156178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Getting the focus back. There's new hope for people with age-related macular degeneration.
    Baldauf S
    US News World Rep; 2007 Mar; 142(8):65-6. PubMed ID: 17348339
    [No Abstract]   [Full Text] [Related]  

  • 6. Vascular Inflammation Risk Factors in Retinal Disease.
    Soto I; Krebs MP; Reagan AM; Howell GR
    Annu Rev Vis Sci; 2019 Sep; 5():99-122. PubMed ID: 31226014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overview of age-related ocular conditions.
    Akpek EK; Smith RA
    Am J Manag Care; 2013 May; 19(5 Suppl):S67-75. PubMed ID: 23725498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Eger Macular Stressometer: pilot study.
    Schmitt NJ; Grover DA; Feldon SE
    Am J Ophthalmol; 2003 Aug; 136(2):314-7. PubMed ID: 12888055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced glycation end products (AGEs) and diabetic vascular complications.
    Yamagishi S; Nakamura K; Imaizumi T
    Curr Diabetes Rev; 2005 Feb; 1(1):93-106. PubMed ID: 18220586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical studies of advanced glycation end product inhibitors and diabetic kidney disease.
    Williams ME
    Curr Diab Rep; 2004 Dec; 4(6):441-6. PubMed ID: 15539009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic targeting of advanced glycation end-products in age-related diseases.
    Rowan S; Bejarano E; Taylor A
    Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3631-3643. PubMed ID: 30279139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of advanced glycation end-products (AGE) in late diabetic complications.
    Sensi M; Pricci F; Pugliese G; De Rossi MG; Petrucci AF; Cristina A; Morano S; Pozzessere G; Valle E; Andreani D
    Diabetes Res Clin Pract; 1995 Apr; 28(1):9-17. PubMed ID: 7587917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validity and reliability study for the NEI-VFO-39 scale in chronic ophthalmic diseases--Turkish version.
    Iyigun E; Bayer A; Tastan S; Demiralp M; Acikel C
    Acta Ophthalmol; 2010 Jun; 88(4):e115-9. PubMed ID: 20346083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Burden of Vision Impairment and Eye Diseases in Persons with Chronic Kidney Disease - A Population-Based Study.
    Wong CW; Lamoureux EL; Cheng CY; Cheung GC; Tai ES; Wong TY; Sabanayagam C
    EBioMedicine; 2016 Mar; 5():193-7. PubMed ID: 27077127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Aminoguanidine and other AGE inhibitors].
    Kawakami M; Kuroki M
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():601-5. PubMed ID: 12387057
    [No Abstract]   [Full Text] [Related]  

  • 16. The Evolving Functions of Autophagy in Ocular Health: A Double-edged Sword.
    Chai P; Ni H; Zhang H; Fan X
    Int J Biol Sci; 2016; 12(11):1332-1340. PubMed ID: 27877085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of cardiovascular and renal pathology of aging by the advanced glycation inhibitor aminoguanidine.
    Li YM; Steffes M; Donnelly T; Liu C; Fuh H; Basgen J; Bucala R; Vlassara H
    Proc Natl Acad Sci U S A; 1996 Apr; 93(9):3902-7. PubMed ID: 8632987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visual complications in diabetes mellitus: beyond retinopathy.
    Khan A; Petropoulos IN; Ponirakis G; Malik RA
    Diabet Med; 2017 Apr; 34(4):478-484. PubMed ID: 27917530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced glycation end-products are responsible for the impairment of corpus cavernosal smooth muscle relaxation seen in diabetes.
    Cartledge JJ; Eardley I; Morrison JF
    BJU Int; 2001 Mar; 87(4):402-7. PubMed ID: 11251537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. International Diabetes Federation meeting, 1997: nephropathy, retinopathy, and glycation.
    Bloomgarden ZT
    Diabetes Care; 1998 Sep; 21(9):1560-6. PubMed ID: 9727909
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.